US Patent Issued to MEDICOVESTOR on March 25 for "Methods of using immunotherapeutics that bind folate receptor alpha" (Delaware Inventor)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,396, issued on March 25, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).

"Methods of using immunotherapeutics that bind folate receptor alpha" was invented by Seah Lim (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes methods of using proteins that specifically bind human folate receptor alpha (FRalpha) with high affinity. These proteins include a recombinant human anti-FRalpha IgG1 that is suitable for use as a therapeutic antibody to treat cancers that express FRalpha. Other FRalpha-binding proteins are also described including antibody fragments, antibody conjugates, and fusion proteins."

The paten...